• 1. CDC Malaria Questionnaire on Hydro-chloroquine safety. CLICK HERE

• 2.   US National Library of Medicine National Institutes of Health: "our investigation of a large national cohort appears to support early administration (within the first 3 to 7 days of COVID-19 diagnosis) of HCQ in mild COVID-19 disease in an outpatient setting for reducing hospitalizations and deaths without any serious adverse HCQ-related effects." If this finding is confirmed in future clinical trials, HCQ as a cheap and available drug may still play a role in a specific population with respect to reducing COVID-19 burden, particularly in resource-poor countries.
  
• America's Frontline Doctors: Scroll down on the front page for ways to access    Hydroxychloroquine an/or Ivermectin Click Here

• Michael Yon Interview with The Epoch Times on  Illegal Immigration through the Darian  Gap and CNN encouraging immigrants to take the risk causing a humanitarian crisis.  Subscription Required to view video. Click here for the video link and how to subscribe. 

 Hydroxychloroquine

•  Lancet Study: One of the most, if not the most, respected medical journals in the country published a study that claimed that the drug was harmful. 
•  The study authors said they launched an independent review to confirm the findings but said the company would not provide access to all the data.
• "Based on this development, we can no longer vouch for the veracity of the primary data sources," the authors wrote.
• Claimed, data from 96,000 COVID-19 patients from 671 hospitals on six continents. The findings suggested hydroxychloroquine did not benefit patients and was associated with an increased risk of dying in the hospital
•  The study stayed published for more than two weeks during which time major media outlets (CNN, Fox Business News, WHO and more) ran with the story in mass to get the word out that the drug could be deadly. 
•  Henry Ford Health System:  Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.